MedCity News

JANUARY 15, 2024

Morgan Healthcare Conference, CEO Joshua Brumm said Dyne’s existing cash combined with the new capital is expected to last through 2025—well beyond the next key milestones for both therapeutic candidates. At the J.P.

Medicine 118

Medicine Healthcare Healthcare Biopharma 118

European Pharmaceutical Review

NOVEMBER 3, 2022

Companies intend to report emissions for these trials from 2025. Ensure more than 90 percent of trials starting in 2025 include a review of how digital solutions can lower emissions. The post Seven pharma CEOs unite to achieve emission targets appeared first on European Pharmaceutical Review.

Pharma 98

Pharma Government Pharmaceutical Healthcare 98

European Pharmaceutical Review

DECEMBER 19, 2024

However, the road to successful implementation is fraught with concerns around data privacy, workflow integration, and acceptance by both patients and physicians, stated Sachin Gharat, Associate Project Manager, Pharma at GlobalData. In 2025, organisations must focus on addressing data integrity challenges. 2024; 177: 108632.

Pharmaceutical 52

Pharmaceutical Ethics Medicine Pharma 52

pharmaphorum

JANUARY 10, 2023

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. Pharma is a highly regulated industry and that is often why it is slow to adopt new technologies,” says Kazuki.

Marketing 98

Marketing Pharma Healthcare Healthcare 98

pharmaphorum

JANUARY 9, 2023

Biopharma and healthcare group Chiesi Farmaceutici S.p.A. is to acquire the 2015-established Amryt Pharma Plc. The post Chiesi expands rare disease portfolio with Amryt Pharma acquisition appeared first on. in an all-cash transaction at $14.50 per American Depositary Share (ADS). Each ADS represents five Amryt ordinary shares.

Pharma 98

Pharma Biopharma Management Medicine 98

Pharma Marketing Network

DECEMBER 17, 2021

Big pharma has compelling reasons to change the way business gets done. Sunny White is an Editorial Advisory Board member for the Pharma Marketing Network with unique insights into how sustainability is moving across the value chain in the pharmaceutical industry. What is Big Pharma doing to tackle climate change? Sunny White.

Pharma 103

Pharma Ethics Recruitment Government 103

Impetus Digital

JANUARY 13, 2023

The growing role of artificial intelligence (AI) and the importance of the “human aspect” throughout Pharma operations. After more than two years of pandemic restrictions, many Pharma leaders are itching to meet with their key opinion leaders (KOLs) in person again, believing that’s what most KOLs want.

Pharma 95

Pharma Medical Patients Healthcare 95

Pharma Marketing Network

NOVEMBER 15, 2024

But with tight budgets and an evolving landscape, how can pharma professionals effectively connect in 2025 without breaking the bank? Leverage Virtual Platforms The pandemic taught us the power of virtual connectivity, and in 2025, this trend continues. For more insights, check out Pharma Marketing.

Networking 40

Networking Pharma Marketing CRM 40

Pharma Marketing Network

NOVEMBER 15, 2024

But with strict regulations and evolving consumer expectations, how do pharma brands navigate the digital landscape effectively? Pharma professionals should take the time to research and segment their audience. Are you trying to engage healthcare professionals (HCPs), patients, or caregivers? Why It Works: People trust people.

Media 52

Media Pharma Marketing Medical 52

European Pharmaceutical Review

AUGUST 1, 2022

The joint Big Data Steering Group of the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) has published a third workplan, setting actions to be delivered by 2025. According to EMA, the new plan will further enhance the efficient integration of data analysis into the regulatory evaluation of medicinal products.

Medicine 105

Medicine Networking Electronics Healthcare 105

Clarivate

APRIL 24, 2023

healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. Payers are responding by creating, acquiring or fortifying provider networks and healthcare clinics of their own.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

PM360

JUNE 29, 2022

By 2025, sales of consumer health products are expected to reach $368bn, according to Euromonitor, encompassing everything from sleep aids to vitamins to sports nutrition products. Healthcare and pharma companies are watching this trend and refining their strategies to meet tomorrow’s health consumer.

Retail 97

Retail Marketing Healthcare Healthcare 97

Pharma Leaders

AUGUST 17, 2022

When I started working on my first projects in pharma and life sciences, I verified this personally. Today, healthcare professionals and patients have the highest awareness of pharma brands than ever before. It works not just in pharma but in other medical-related industries.

Pharma 52

Pharma Marketing Healthcare Healthcare 52

Eversana Intouch

DECEMBER 13, 2024

We must ensure our messaging is tailored to apply and resonate across cultures, languages, regulations and healthcare systems. Correspondingly, pharmaceutical manufacturers spend exponentially more on marketing healthcare, including more than $6 billion annually on direct-to-consumer advertising. If it were easy, wed all be doing it.

Marketing 52

Marketing Manufacturing Healthcare Ethics 52

Clarivate

OCTOBER 31, 2023

These years witnessed significant troughs in pharma financing, a drop in the capital markets, and an IPO window that remained firmly shut. Big pharma is still keen to access good technology, science, and assets, in many cases to plug a patent-expiry-shaped hole in their coffers. In short, the biotech bubble had burst. Pfizer’s $11.6

Pharma 52

Pharma Biopharma Marketing Healthcare 52

Clarivate

JANUARY 23, 2024

R&D spend is steadily growing and is expected to reach approximately $200 billion by 2025. To learn more about how Clarivate and CMR International help pharmas future-proof their portfolios, please visit us here. The post Pharma R&D productivity dips, but efficiency gains give hope appeared first on Clarivate.

Pharma 52

Pharma Sales Consulting Pharmaceutical 52

pharmaphorum

OCTOBER 10, 2022

Customer demands encouraged new partnerships among healthcare providers and technology companies. Nowadays, new health tech, pharma, or biotech companies work with a minimum of five partners throughout a product’s inception, drastically speeding up the idea-to-market timeline. The future of health tech. About the author.

Food 111

Food Marketing Healthcare Healthcare 111

Pharmaceutical Technology

JULY 21, 2022

As part of ESG (Environmental, Social, and Governance), the social good delivered by robust healthcare systems are at the core of healthy populations. The Covid-19 pandemic has demonstrated how vital patient access to quality and affordable healthcare is for patients all over the world. Climate change and ESG. Access to medication.

Government 52

Government Healthcare Healthcare Pharma 52

Penrod

JUNE 6, 2024

Health Cloud was a version of Salesforce CRM tailored to healthcare providers, insurance companies, and other organizations’ unique needs with patient-focused business models. To some extent, this patient model fits the requirements of med dev and pharma pretty well, but it wasn’t one-size-fits-all.

CRM 52

CRM Food and Drug Administration Healthcare Provider Management 52

PM360

OCTOBER 8, 2024

First of its kind, in-office, digital hub enhances provider efficiency and care team collaboration Cincinnati, Ohio – October 7, 2024 – PatientPoint® a leading digital health company, today showcased the transformation of its healthcare professional solution with the launch of an interactive, in-office digital hub.

Healthcare Provider 52

Healthcare Provider Pharma reps Pharma Rep Physicians 52

pharmaphorum

JULY 8, 2022

The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial space. A recent Science 37 survey noted that nearly three-quarters (73%) of respondents from the pharma industry were planning a hybrid or DCT, up from 49% in 2021. Novel digital endpoints. Source: Landers et al.,

Pharma 100

Pharma Patients FDA Marketing 100

pharmaphorum

OCTOBER 12, 2022

He explains that bringing cutting-edge genomic therapies to market which could treat or cure life-threatening diseases can take up to 15 years and cost $2 billion – far too slow to match patients’ needs, and far too expensive on the healthcare system. “We By 2025, pharma’s investment in AI is expected to reach $3 billion.

Medicine 105

Medicine Patients Healthcare Healthcare 105

pharmaphorum

NOVEMBER 9, 2022

The present moment within and without healthcare, biotech, and pharma is a difficult and pivotal time in history, a time in which such issues need must be addressed. However, what is clearer still is that vulnerable groups need support and healthcare systems need to adapt to become stronger and more resistant.

Insurance 98

Insurance Patients Healthcare Healthcare 98

pharmaphorum

JULY 22, 2022

Advances in Pharma 4.0 In 2025, the global cleanroom technology market is expected to reach nearly $5 billion. Sponsored by Ecolab, Elis Cleanroom, Innerspace, Microgenetics, Novatek. Co-Chaired by: Conor Murray, Chairman, Irish Cleanroom Society and Connor McMorrow, Aseptic Lead Cell Therapy, Takeda.

Pharmaceutical 52

Pharmaceutical Management Engineering Media 52

PM360

AUGUST 9, 2022

With these launches came more complex science, which pushed biopharma’s evolution to integrate more medical engagement alongside the existing commercial focus for healthcare providers and payers. Innovation Is Expanding, But Healthcare Systems Are Slow to Adapt. Challenges of the New World Order.

Biopharma 69

Biopharma Marketing Healthcare Healthcare 69

PM360

AUGUST 9, 2022

billion in 2025. One reason for this growth is an increasing demand for personalized healthcare technologies as patients look for advances in how healthcare is delivered following the pandemic. Pharma Manufacturer Solutions. from 2021 and reach $4.2 Furthermore, it is estimated to reach $6.5 Aaron Crittenden.

Prescription 105

Prescription Medical Patients Side effects 105

Clarify Health

JULY 13, 2020

The panel included Bhash Parasuraman, PhD, Vice President and BU Lead, Rare Disease Patient & Health Impact, Pfizer , Calum MacRae, MD, PhD, Professor of Medicine at Harvard Medical School , and Surya Singh, MD, President, Singh Healthcare Advisors. By 2025, several new gene and cell therapies will be coming to market.

Pharmaceutical 52

Pharmaceutical Pharma Patients Marketing 52

pharmaphorum

JANUARY 4, 2023

providing personalised healthcare consisting in assessing, maintaining, or restoring the state of health of individuals. The EC is hoping that, by the end of its current mandate on 31 October 2024, the legislative process will be completed, with the EHDS becoming operational in 2025.

Pharmaceutical 98

Pharmaceutical Electronics Healthcare Healthcare 98

Contrarian Sales Techniques

FEBRUARY 25, 2023

And I remember when I go out to the field and customers started to doubt the quality of generic products, I always use the Twynsta example where the product is manufactured by Cipla and distributed by Bohringer Ingelheim, a pharma company from Germany. But the local generic meds market scenario in Malaysia is totally different.

Marketing 52

Marketing Distribution Medical Government 52

Clarivate

MAY 13, 2024

After staying relatively flat for several years, enrollment growth took off in 2021 after an expansion in federal subsidies for silver-level plans passed in the American Rescue Plan and was then renewed through 2025 in the Inflation Reduction Act. Pillo, Senior Healthcare Research and Data Analyst. The post The U.S.

Insurance 52

Insurance Marketing Healthcare Healthcare 52

Healthcare Success

NOVEMBER 7, 2022

Best-in-class healthcare marketers are already planning for next year. According to Axios, traditional pay-TV providers like Comcast, Verizon, and Dish Network have lost a staggering 25 million subscribers since 2012 and are expected to lose another 25 million by 2025. It helps show healthcare consumers you care. People are 1.6

Marketing 52

Marketing Media Healthcare Healthcare 52

Impetus Digital

APRIL 24, 2023

A Vision for Medical Affairs In A Vision for Medical Affairs in 2025 –a recent McKinsey & Company report–the authors provided thought-provoking insights into the evolution of MA, mirroring what we have been hearing first-hand. Nevertheless, some Pharma executives have been resistant to wholly embracing digital transformation.

Medical 52

Medical Education Physicians Healthcare 52

European Pharmaceutical Review

DECEMBER 18, 2023

In 2023, the pharma industry has] witnessed tremendous advances in CAR T-cell immunotherapy of solid tumours” Another treatment modality that has witnessed significant advancement this year in the pharmaceutical industry, is cell and gene therapy. According to CPI, the facility is set to be completed in late 2025.

Manufacturing 98

Manufacturing Food and Drug Administration Medicine Pharmaceutical manufacturing 98

PM360

AUGUST 26, 2024

Fortune 500s or Start-Ups; what are the opportunities and challenges for top school business graduates to consider for the Healthcare/Pharma/Biotech vertical? A: (Galeota) MIT Sloan’s and all MIT students should consider the tremendous career opportunities that the Healthcare/Pharma/Biotech vertical offers.

Distribution 52

Distribution Biopharma Healthcare Healthcare 52

European Pharmaceutical Review

APRIL 30, 2024

I see the market picking back up towards the end of 2024 or early 2025. With over two decades of experience in the life science industry, Vikas has held various senior positions in pharma and bioprocessing companies such as Repligen, GE Healthcare, Merck Millipore and Bayer.

Manufacturing 97

Manufacturing Food and Drug Administration Biopharma Marketing 97

Scott Burrows

DECEMBER 13, 2024

Heres to embracing every opportunity, conquering every challenge, and making 2025 a year to remember. With a clear vision, a positive mindset, and unwavering grit, youre setting the stage for a year filled with growth, resilience, and extraordinary achievement. Dream big, work hard, and step boldly into the possibilities aheadyouve got this!

Management 52

Management Engineering Safety Insurance 52

PM360

JUNE 16, 2023

The healthcare industry has been transformed by the COVID-19 pandemic, and the diagnostic market is no exception. This has led to significant changes in the healthcare diagnostics market and has created new opportunities and challenges for pharma executives. billion in 2021, is expected to grow at an annual rate of 28.1%

Marketing 52

Marketing Healthcare Healthcare Medical 52